YourHealthRx
YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network.
- Semaglutide
- $170/mo (compounded)
- Tirzepatide
- $210/mo (compounded)
- Coverage
- All 50 states
- Brand-name
- Not confirmed
Weigh YourHealthRx against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.
Factor breakdown
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.
Strengths
- Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
- Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
- Flat subscription price that doesn't change as your dose increases (no titration penalty)
- Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
- Transparent, education-first positioning with published medical disclaimer, privacy, and terms
What to consider
- Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
- Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
- Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
- No LegitScript certification displayed
Bottom line — Grade C
Best for: Shoppers who want science-forward GLP-1 and peptide care nationwide, with flat-rate dosing and built-in clinical follow-up.
Site position #135 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.
Closest here
The rankings grading nearest YourHealthRx — the realistic shortlist.
GoodRx offers free prescription discounts and a separate $39 monthly weight-loss care subscription; branded medication, dose discounts and refill conditions need a separate quote.
Jyra Health is an online weight-loss and longevity telehealth clinic offering compounded GLP-1 — semaglutide from $99/mo and tirzepatide from $133/mo (limited time) — prescribed by board-certified providers in all 50 states, with no insurance, no monthly membership, no hidden fees, and free express delivery.
Medi-Weightloss is an established physician-supervised weight-loss brand with 130-plus locations nationwide plus telehealth.
Telehealth weight-loss program offering compounded GLP-1 medications (weekly injections and daily dissolvable tablets) plus limited brand-name options, prescribed by US-licensed providers and shipped to your home.
Cielo is a compounded-GLP-1-only telehealth platform offering semaglutide and tirzepatide with no brand-name drugs and no TRT, hair, or mental-health add-ons — a focused, single-purpose alternative to multi-vertical providers.
Pomegranate Health sells compounded semaglutide and tirzepatide with no membership and no consultation fee.
The 21 rankings nearest this one
- #139 Silhouette MD69.4
- #140 Trillium Meds69.4
- #141 Calibrate Health69.3
- #142 LifeRx.md69.3
- #143 Pallas Health69.3
- #144 RENN Health69.3
- #145 RxPros69.3
- #146 BioGlow Health69.2
- #147 GobyMeds69.2
- #148 Kin Meds69.1
- #149 AZ Health69
- #150 NuBloom69
- #151 Tonik Wellness69
- #152 Ozari Health68.9
- #153 WeightWatchers Clinic68.8
- #154 Fidelity Medical Clinic68.7
- #155 Lavender Sky Health68.7
- #156 Measured68.7
- #157 RxPepsDirect68.7
- #158 Somi Health68.7
- #159 GOAL.MD68.6
Pricing/verification reflect YourHealthRx's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on YourHealthRx's site. Not medical advice; see our disclosure.